Variation_Name | GeneID | GeneSymbol | ClinicalSignificance | dbSNP | RCVaccession | TestedInGTR | PhenotypeIDs | Chromosome | Start | Stop | HGVS_c | HGVS_p | HGVS_g | OtherIDs | Disease_ClinVar | Disease_hgmd | NM_002693.2(POLG):c.3218C>T (p.Pro1073Leu) | 5428 | POLG | Pathogenic | 267606959 | RCV000014470; RCV000014471; RCV000188673; | N | MedGen:C0205710,OMIM:203700,ORPHA:726,SNOMED CT:20415001; MedGen:C3150914,OMIM:613662; MedGen:CN221809 | 15 | 89862217 | 89862217 | NM_002693.2:c.3218C>T | NP_002684.1:p.Pro1073Leu | NC_000015.9:g.89862217G>A | OMIM Allelic Variant:174763.0022 | C3150914 613662 Mitochondrial DNA depletion syndrome 4B, MNGIE type; CN221809 not provided; C0205710 203700 Progressive sclerosing poliodystrophy | | |
NM_002693.2(POLG):c.2617G>T (p.Glu873Ter) | 5428 | POLG | Pathogenic | 121918047 | RCV000014453; | N | MedGen:C0205710,OMIM:203700,ORPHA:726,SNOMED CT:20415001 | 15 | 89864473 | 89864473 | NM_002693.2:c.2617G>T | NP_002684.1:p.Glu873Ter | NC_000015.9:g.89864473C>A | OMIM Allelic Variant:174763.0008 | C0205710 203700 Progressive sclerosing poliodystrophy | | |
NM_002693.2(POLG):c.2542G>A (p.Gly848Ser) | 5428 | POLG | Pathogenic | 113994098 | RCV000014450; RCV000014449; RCV000014451; RCV000014452; RCV000188580; | N | MedGen:C0205710,OMIM:203700,ORPHA:726,SNOMED CT:20415001; MedGen:C1850303,OMIM:258450,ORPHA:254886; MedGen:C1868097; MedGen:C3150914,OMIM:613662; MedGen:CN221809 | 15 | 89865023 | 89865023 | NM_002693.2:c.2542G>A | NP_002684.1:p.Gly848Ser | NC_000015.9:g.89865023C>T | OMIM Allelic Variant:174763.0006 | C1850303 258450 Cerebellar ataxia infantile with progressive external ophthalmoplegia; C3150914 613662 Mitochondrial DNA depletion syndrome 4B, MNGIE type; CN221809 not provided; C0205710 203700 Progressive sclerosing poliodystrophy | | |
NM_002693.2(POLG):c.2243G>C (p.Trp748Ser) | 5428 | POLG | Pathogenic;Uncertain significance | 113994097 | RCV000014459; RCV000014460; RCV000014461; RCV000080023; RCV000144870; | N | MedGen:C0007959, Orphanet:ORPHA166,SNOMED CT:50548001; MedGen:C0205710,OMIM:203700,ORPHA:726,SNOMED CT:20415001; MedGen:C1843851,OMIM:607459,ORPHA:70595; MedGen:C1843852; MedGen:CN221809 | 15 | 89866657 | 89866657 | NM_002693.2:c.2243G>C | NP_002684.1:p.Trp748Ser | NC_000015.9:g.89866657C>G | HGMD:CM042764,OMIM Allelic Variant:174763.0013 | C0007959 Charcot-Marie-Tooth disease; C1843852 Myoclonic epilepsy myopathy sensory ataxia; CN221809 not provided; C0205710 203700 Progressive sclerosing poliodystrophy; C1843851 607459 Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | | |
NM_002693.2(POLG):c.2243G>C (p.Trp748Ser) | 5428 | POLG | Pathogenic;Uncertain significance | 113994097 | RCV000014459; RCV000014460; RCV000014461; RCV000080023; RCV000144870; | N | MedGen:C0007959, Orphanet:ORPHA166,SNOMED CT:50548001; MedGen:C0205710,OMIM:203700,ORPHA:726,SNOMED CT:20415001; MedGen:C1843851,OMIM:607459,ORPHA:70595; MedGen:C1843852; MedGen:CN221809 | 15 | 89866657 | 89866657 | NM_002693.2:c.2243G>C | NP_002684.1:p.Trp748Ser | NC_000015.9:g.89866657C>G | HGMD:CM042764,OMIM Allelic Variant:174763.0013 | C0007959 Charcot-Marie-Tooth disease; C1843852 Myoclonic epilepsy myopathy sensory ataxia; CN221809 not provided; CN169374 not specified; C0205710 203700 Progressive sclerosing poliodystrophy; C1843851 607459 Sensory ataxic neuropathy, dysarthria, an | | |
NM_002693.2(POLG):c.1399G>A (p.Ala467Thr) | 5428 | POLG | Pathogenic | 113994095 | RCV000014441; RCV000184011; RCV000014440; RCV000014442; RCV000014443; RCV000188658; | N | MedGen:C0205710,OMIM:203700,ORPHA:726,SNOMED CT:20415001; MedGen:C1834846,OMIM:157640; MedGen:C1843851,OMIM:607459,ORPHA:70595; MedGen:C1843852; MedGen:C1850303,OMIM:258450,ORPHA:254886; MedGen:CN221809 | 15 | 89870432 | 89870432 | NM_002693.2:c.1399G>A | NP_002684.1:p.Ala467Thr | NC_000015.9:g.89870432C>T | OMIM Allelic Variant:174763.0002 | C1834846 157640 Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 1; C1850303 258450 Cerebellar ataxia infantile with progressive external ophthalmoplegia; C1843852 Myoclonic epilepsy myopathy sensory ataxia; CN221 | | |
NM_002693.2(POLG):c.752C>T (p.Thr251Ile) | 5428 | POLG | Pathogenic;Uncertain significance | 113994094 | RCV000014447; RCV000184009; RCV000014448; RCV000020484; RCV000188641; RCV000194055; | N | MedGen:C0205710,OMIM:203700,ORPHA:726,SNOMED CT:20415001; MedGen:C0872218,OMIM:603041; MedGen:C1850303,OMIM:258450,ORPHA:254886; MedGen:C3150914,OMIM:613662; MedGen:CN169374; MedGen:CN221809 | 15 | 89873415 | 89873415 | NM_002693.2:c.752C>T | NP_002684.1:p.Thr251Ile | NC_000015.9:g.89873415G>A | OMIM Allelic Variant:174763.0007 | C1850303 258450 Cerebellar ataxia infantile with progressive external ophthalmoplegia; C3150914 613662 Mitochondrial DNA depletion syndrome 4B, MNGIE type; C0872218 603041 Myoneural gastrointestinal encephalopathy syndrome; CN221809 not provided; CN1693 | | |